ORADEL

Details for Australian Trade Mark No. 1133872 (hide)

Classes

Class 5 Orally ingested pharmaceutical preparations for the treatment of dermatological, metabolic, immunological, musculo-skeletal, chronic systemic and central nervous system disorders such as: psoriasis; arthritis, including rheumatoid arthritis; inflammatory bowel disease; muscle tearing and related inflammation; diabetes, including type 1 and type 2 diabetes; aids-related illnesses; cancers and their various associated pathologies; chronic renal failure; chronic cardiovascular disease, including heart failure; multiple sclerosis, dementia, parkinson's disease, huntington's chorea; neuron-psychiatric disorders, including major depression, bipolar depression, schizophrenia and allied disorders; orally ingested pharmaceutical preparations for the treatment of infectious diseases such as malaria, hepatitis, including hepatitis A, B and C, HIV, influenzas, tuberculosis, bacterial and fungal infections

Event Publications

28 September 2006 Application filed

18 January 2007 Application Accepted

19 July 2007 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.